Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.32B |
| 2 |
D.R. Horton
DHI
|
+$1.01B |
| 3 |
NVIDIA
NVDA
|
+$970M |
| 4 |
Micron Technology
MU
|
+$946M |
| 5 |
Netflix
NFLX
|
+$897M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.73B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.7B |
| 3 |
Apple
AAPL
|
+$1.7B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.54B |
| 5 |
Microsoft
MSFT
|
+$1.22B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.91% |
| 2 | Healthcare | 17.33% |
| 3 | Industrials | 12.86% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Centene
CNC
$33.1B
| $228M | 0.07% |
2,782,295
-47,438
| -2% | -$3.87M |
|
202
Merck
MRK
$328B
| $226M | 0.07% |
2,037,894
+977
| +0% | +$99.9K |
|
|
SRCL
203
DELISTED
Stericycle Inc
SRCL
| $225M | 0.07% |
4,514,922
+75,308
| +2% | +$3.58M |
|
204
McCormick & Company Non-Voting
MKC
$14.2B
| $225M | 0.07% |
2,713,521
-371
| -0% | -$29.9K |
|
205
MongoDB
MDB
$35.2B
| $220M | 0.07% |
1,116,974
-782,252
| -41% | -$139M |
|
206
Steel Dynamics
STLD
$37.7B
| $217M | 0.07% |
2,222,330
+200,139
| +10% | +$19.3M |
|
207
Agilon Health
AGL
$1.45B
| $217M | 0.07% |
537,142
-22,401
| -4% | -$10.5M |
|
208
Integra LifeSciences
IART
$1.35B
| $214M | 0.06% |
3,823,726
+702,779
| +23% | +$35.8M |
|
209
Amphenol
APH
$210B
| $214M | 0.06% |
5,625,634
-772
| -0% | -$29.2K |
|
210
Pfizer
PFE
$150B
| $213M | 0.06% |
4,158,180
+679,981
| +20% | +$32.6M |
|
211
Cullen/Frost Bankers
CFR
$10.4B
| $211M | 0.06% |
1,579,942
-662,064
| -30% | -$94.1M |
|
212
Coca-Cola
KO
$373B
| $209M | 0.06% |
3,277,791
-5,176,552
| -61% | -$313M |
|
213
Cisco
CSCO
$488B
| $201M | 0.06% |
4,220,333
-659
| -0% | -$30K |
|
|
SCHW
214
Charles Schwab
SCHW
$189B
| $200M | 0.06% |
2,401,294
-2,134,014
| -47% | -$166M |
|
215
Alnylam Pharmaceuticals
ALNY
$30B
| $198M | 0.06% |
+832,117
| New | +$177M |
|
|
AZEK
216
DELISTED
The AZEK Co
AZEK
| $197M | 0.06% |
9,712,794
+7,688,535
| +380% | +$142M |
|
217
DT Midstream
DTM
$13.9B
| $196M | 0.06% |
3,542,640
-729,573
| -17% | -$41.7M |
|
218
CONMED
CNMD
$1.48B
| $194M | 0.06% |
2,192,394
+452,982
| +26% | +$37.6M |
|
219
S&P Global
SPGI
$121B
| $193M | 0.06% |
575,673
-882,984
| -61% | -$291M |
|
220
Thor Industries
THO
$4.11B
| $191M | 0.06% |
2,526,116
-57,984
| -2% | -$4.66M |
|
221
Euronet Worldwide
EEFT
$2.66B
| $190M | 0.06% |
2,017,265
+424,916
| +27% | +$36.8M |
|
222
Paycom
PAYC
$9.52B
| $189M | 0.06% |
608,805
-319,905
| -34% | -$103M |
|
|
LNW
223
DELISTED
Light & Wonder
LNW
| $188M | 0.06% |
3,203,862
+423,200
| +15% | +$24.2M |
|
224
Helen of Troy
HELE
$696M
| $182M | 0.06% |
1,645,219
+304,150
| +23% | +$29.6M |
|
225
Icon
ICLR
$12.9B
| $181M | 0.05% |
929,761
+37,268
| +4% | +$7.39M |
|
Similar funds
Capital Research Global Investors's Q4 2022 Portfolio in Review
As of Q4 2022, Capital Research Global Investors held 466 positions worth $331B, up 8.7% from $304B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q4 2022 filing shows 37 new, 178 increased, 165 reduced and 30 closed positions. Its largest new stake was Boeing: 8,097,785 shares worth $1.54B. The largest sale was Amazon, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.
- Capital Research Global Investors's largest Q4 2022 buy was Boeing: 8,097,785 shares worth $1.54B.
- Capital Research Global Investors added most to D.R. Horton in Q4 2022, an estimated $1.01B increase.
- Capital Research Global Investors's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.73B.
- Capital Research Global Investors fully exited SVB Financial Group in Q4 2022, selling an estimated $654M.
- Capital Research Global Investors's ten largest holdings make up 27% of its $331B portfolio in Q4 2022.
- Capital Research Global Investors opened 37 new positions and closed 30 in Q4 2022.
- Capital Research Global Investors's portfolio value rose 8.7% quarter-over-quarter to $331B.
Based on Capital Research Global Investors's 13F filing for Q4 2022, filed 14 Feb 2023.